A new device to treat gastroesophageal reflux disease (GERD)
Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device
This study is testing a new, easy-to-use device called the Ω-Cuff that helps people with gastroesophageal reflux disease (GERD) by reducing acid reflux without surgery that changes the esophagus, so you can feel better and rely less on medications.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aplos Medical INC NIH-funded |
| Lab location | 1 site (Eden Prairie, United States) |
| Project ID | NIH-10634514 on NIH RePORTER |
What this research studies
This research focuses on developing a flexible, non-occlusive device called the Ω-Cuff to treat gastroesophageal reflux disease (GERD). GERD occurs when stomach acid frequently flows back into the esophagus, causing discomfort and potential serious health issues. The Ω-Cuff is designed to be implanted using a minimally invasive laparoscopic procedure, which avoids altering the anatomy of the esophagus. This device aims to reduce reliance on long-term medications and improve patient outcomes by providing a safer and more effective treatment option.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from gastroesophageal reflux disease who are seeking alternatives to medication or traditional surgical options.
Not a fit: Patients who do not have GERD or those who are not suitable candidates for surgical interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more effective treatment for GERD, reducing the need for medications and improving quality of life for patients.
How similar studies have performed: Other research has shown success with similar minimally invasive approaches to treating GERD, indicating potential for this novel device.
Where this research is happening
Eden Prairie, United States
- Aplos Medical INC — Eden Prairie, United States (Active)
Researchers
- Principal investigator: Tihon, Claude Nmn — Aplos Medical INC
- Study coordinator: Tihon, Claude Nmn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.